Inactive Instrument

Other languages Depomed Inc Nasdaq

Equities

US2499081048

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

James L. Tyree, Chairman of the Compensation Committee of the Board of Directors of Assertio Holdings, Inc. Declines to Stand for Reelection	Apr. 02
Assertio Holdings, Inc. Appoints Sigurd Kirk to the Board, Effective April 3, 2024	Mar. 11
Assertio Holdings, Inc. Provides Earnings Guidance for the Year 2024	Mar. 11
Assertio Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 11
Assertio Holdings, Inc. Announces the Resignation of Daniel A. Peisert as Member of the Board of Directors	Jan. 26
Assertio Holdings, Inc. Announces Executive Changes	Jan. 05
Assertio Holdings CEO Steps Down, Names Interim CEO	Jan. 03
Assertio Holdings, Inc. Announces CEO Changes	Jan. 03
Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors	Nov. 14
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech	Nov. 09
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading	Nov. 09
Top Premarket Decliners	Nov. 09
Assertio Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08
Assertio Holdings, Inc. Announces Executive Changes	Nov. 08
Top Midday Decliners	23-08-04
Assertio Therapeutics Completes Acquisition of Spectrum Pharmaceuticals, Reports Lower Q2 Adjusted Earnings	23-08-04
Assertio Holdings, Inc. Withdraws Earnings Guidance for the Year 2023	23-08-03
Assertio Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03
Assertio Holdings Closes Acquisition of Spectrum Pharmaceuticals	23-08-01
Assertio Holdings, Inc. Appoints Jeffrey Vacirca to Its Board of Directors	23-07-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Depomed Inc Nasdaq

Equities

US2499081048

Other languages

Filters